Soleno Therapeutics Stock Current Valuation
| SLNO Stock | USD 49.70 0.14 0.28% |
Valuation analysis of Soleno Therapeutics helps investors to measure Soleno Therapeutics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Soleno Therapeutics' price fluctuation is very steady at this time. Calculation of the real value of Soleno Therapeutics is based on 3 months time horizon. Increasing Soleno Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Soleno Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Soleno Stock. However, Soleno Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 49.7 | Real 50.35 | Hype 49.84 | Naive 49.69 |
The intrinsic value of Soleno Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Soleno Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Soleno Therapeutics helps investors to forecast how Soleno stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Soleno Therapeutics more accurately as focusing exclusively on Soleno Therapeutics' fundamentals will not take into account other important factors: Soleno Therapeutics Company Current Valuation Analysis
Soleno Therapeutics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Soleno Therapeutics Current Valuation | 1.9 B |
Most of Soleno Therapeutics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Soleno Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Soleno Therapeutics has a Current Valuation of 1.9 B. This is 86.81% lower than that of the Biotechnology sector and 59.2% lower than that of the Health Care industry. The current valuation for all United States stocks is 88.6% higher than that of the company.
Soleno Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Soleno Therapeutics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Soleno Therapeutics could also be used in its relative valuation, which is a method of valuing Soleno Therapeutics by comparing valuation metrics of similar companies.Soleno Therapeutics is currently under evaluation in current valuation category among its peers.
Soleno Fundamentals
| Return On Equity | -0.91 | ||||
| Return On Asset | -0.48 | ||||
| Current Valuation | 1.9 B | ||||
| Shares Outstanding | 43.12 M | ||||
| Shares Owned By Insiders | 3.12 % | ||||
| Shares Owned By Institutions | 96.88 % | ||||
| Number Of Shares Shorted | 4.73 M | ||||
| Price To Earning | (3.71) X | ||||
| Price To Book | 8.12 X | ||||
| EBITDA | (37.03 M) | ||||
| Net Income | (38.99 M) | ||||
| Cash And Equivalents | 24.07 M | ||||
| Cash Per Share | 2.97 X | ||||
| Total Debt | 403 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 3.43 X | ||||
| Book Value Per Share | 6.45 X | ||||
| Cash Flow From Operations | (24.94 M) | ||||
| Short Ratio | 8.05 X | ||||
| Earnings Per Share | (2.79) X | ||||
| Target Price | 74.29 | ||||
| Number Of Employees | 33 | ||||
| Beta | -1.44 | ||||
| Market Capitalization | 2.15 B | ||||
| Total Asset | 180.69 M | ||||
| Retained Earnings | (276.41 M) | ||||
| Working Capital | 159.85 M | ||||
| Net Asset | 180.69 M |
About Soleno Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Soleno Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Soleno Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Soleno Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Soleno Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Soleno Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Soleno Stock
| 0.73 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.63 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.63 | DRTS | Alpha Tau Medical | PairCorr |
| 0.52 | DYAI | Dyadic International | PairCorr |
| 0.43 | VCYT | Veracyte | PairCorr |
The ability to find closely correlated positions to Soleno Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Soleno Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Soleno Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Soleno Therapeutics to buy it.
The correlation of Soleno Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Soleno Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Soleno Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Soleno Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Soleno Therapeutics Piotroski F Score and Soleno Therapeutics Altman Z Score analysis. To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soleno Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Soleno Therapeutics is measured differently than its book value, which is the value of Soleno that is recorded on the company's balance sheet. Investors also form their own opinion of Soleno Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Soleno Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soleno Therapeutics' market value can be influenced by many factors that don't directly affect Soleno Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soleno Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.